Jan. 23, 2024Gilead Sciences patents new compounds to treat HIV infectionGilead Sciences Inc. has disclosed compounds reported to be useful for the treatment of HIV infection.
Jan. 23, 2024Reithera, Ragon Institute and IAVI collaborate on HIV vaccineReithera Srl, The Ragon Institute of Mass General, MIT and Harvard, and IAVI have established a collaboration to develop a novel HIV vaccine candidate based on gorilla adenoviral vector (GRAd), with funding by the Bill & Melinda Gates Foundation.
Dec. 21, 2023North American researchers describe new compounds for HIV-1 infectionResearchers at Centre Hospitalier de Université de Montréal and University of Pennsylvania have identified compounds reported to be useful for the treatment of HIV-1 infection.
